SEC 13F Intelligence

Managers / Q2 2020 · view latest →

Tower View Wealth Management LLC

CIK 0001729045 · 4414 N OAKLAND AVE UNIT 406, SHOREWOOD, WI, 53211 · 4142534096

Reported Value
$137M
Q2 2020
Positions
157
Filings on Record
30
2019–present window
Filed
Aug 3, 2020
original filing

Summary

Tower View Wealth Management LLC reported $137M in U.S.-listed holdings across 157 positions for Q2 2020.

Its largest position, LLY, represents 3.0% of the portfolio.

Compared with Q1 2020, the fund opened 46 new positions and exited 8.

Portfolio Metrics

Turnover
+10.9%
vs prior filed quarter
Top-10 Concentration
+27.9%
share of reported value
Largest Position
+3.0%
Eli Lilly Company
New / Exited
46 / 8
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $97MQ4 ’18Q1 ’19: $113MQ2 ’19: $117MQ3 ’19: $121MQ4 ’19: $132MQ4 ’19Q1 ’20: $111MQ2 ’20: $137MQ3 ’20: $154MQ4 ’20: $176MQ4 ’20Q1 ’21: $183MQ2 ’21: $197MQ3 ’21: $180MQ4 ’21: $196MQ4 ’21Q1 ’22: $186MQ2 ’22: $136MQ3 ’22: $131MQ1 ’23: $148,801Q1 ’23Q2 ’23: $147,452Q3 ’23: $142,386Q4 ’23: $161,346Q2 ’24: $174MQ2 ’24Q3 ’24: $183MQ4 ’24: $189MQ1 ’25: $172MQ2 ’25: $193MQ2 ’25Q3 ’25: $193MQ4 ’25: $202MQ1 ’26: $195Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 67.4%ADR: 13.2%ETP: 13.1%Other: 6.2%REIT: 0.1%Other: 0.0%
  • Common Stock · 67.4% · $92M
  • ADR · 13.2% · $18M
  • ETP · 13.1% · $18M
  • Other · 6.2% · $8M
  • REIT · 0.1% · $200,000
  • Other · 0.0% · $6,000

Quarter-over-Quarter Changes full breakdown →

vs Q1 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
VRTXVertex PharmaceuticalsNEW+6.1K6.1K+$2M$2M
Wal-Mart De Mexico ADRNEW+52.5K52.5K+$1M$1M
DOCUDocuSign IncNEW+7.2K7.2K+$1M$1M
SHWSherwin Williams CoNEW+1.9K1.9K+$1M$1M
ADDYYAdidas AGNEW+8.4K8.4K+$1M$1M
PDPagerDuty IncNEW+37.5K37.5K+$1M$1M
WDAYWorkday IncNEW+5.2K5.2K+$968,000$968,000
DBXDropbox IncNEW+42.2K42.2K+$919,000$919,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2020

49 positions
#IssuerClass% PortfolioValueShares
1LLYEli Lilly & Companyhistory →EQUITIES3.04%$4M25.3K
2Nestle ADREQUITIES3.01%$4M37.2K
3GOOGAlphabet Inc.EQUITIES2.88%$4M2.8K
4AMZNAmazon.comhistory →EQUITIES2.82%$4M1.4K
5HDHome Depot Inchistory →EQUITIES2.81%$4M15.3K
6ADBEAdobe Systems Inchistory →EQUITIES2.79%$4M8.8K
7PEPPepsicohistory →EQUITIES2.77%$4M28.6K
8VVisa Inchistory →EQUITIES2.72%$4M19.3K
9S&P 500EQUITIES2.72%$4M12.1K
10MSFTMicrosoft Corphistory →EQUITIES2.65%$4M17.8K
11AAPLApple Inchistory →EQUITIES2.61%$4M9.8K
12PYPLPaypal Holdings Inchistory →EQUITIES2.59%$4M20.3K
13Vanguard Small GrowthEQUITIES2.56%$4M17.6K
14MRSHMarsh & McLennanhistory →EQUITIES2.52%$3M32.1K
15LHXL3Harris Technologieshistory →EQUITIES2.49%$3M20.0K
16VUGVanguard Growth Stockshistory →EQUITIES2.29%$3M15.5K
17TSMTaiwan Semi ADRhistory →EQUITIES2.27%$3M54.8K
18LMTLockheed Martin Corphistory →EQUITIES2.14%$3M8.0K
19KSUEURKansas City Southernhistory →EQUITIES2.08%$3M19.0K
20Merck & Co IncEQUITIES2.06%$3M36.5K
21UNHUnitedHealth Grouphistory →EQUITIES2.05%$3M9.5K
22LRLCYL' Oreal ADRhistory →EQUITIES2.02%$3M42.8K
23EWEdwards Lifescienceshistory →EQUITIES2.02%$3M39.9K
24SYKStryker Corphistory →EQUITIES1.93%$3M14.7K
25LVMUYLVMH Moet ADRhistory →EQUITIES1.90%$3M29.4K
26PGProcter & Gamblehistory →EQUITIES1.83%$2M20.9K
27Vanguard Dividend GrowthEQUITIES1.75%$2M20.4K
28LDOSLeidos Holdings Inchistory →EQUITIES1.72%$2M25.2K
29DISWalt Disney Cohistory →EQUITIES1.69%$2M20.7K
30Elbit Systems ADREQUITIES1.60%$2M16.0K
31WMTWal-Mart Stores Inchistory →EQUITIES1.56%$2M17.8K
32SBUXStarbuckshistory →EQUITIES1.54%$2M28.7K
33NVDANvidia Corphistory →EQUITIES1.50%$2M5.4K
34HESAYHermes Intl ADRhistory →EQUITIES1.46%$2M23.8K
35HXLHexcelhistory →EQUITIES1.42%$2M43.0K
36VAREURVarian Medical Systemshistory →EQUITIES1.40%$2M15.6K
37UNPUnion Pacific Corphistory →EQUITIES1.33%$2M10.7K
38VRTXVertex Pharmaceuticalshistory →EQUITIES1.30%$2M6.1K
39XYZSquare Inchistory →EQUITIES1.22%$2M15.9K
40AXONAxon Enterprise Inchistory →EQUITIES1.13%$2M15.8K
41Vanguard Health CareEQUITIES1.04%$1M7.4K
42Spotify TechnologyEQUITIES1.03%$1M5.5K
43VDCVanguard Cons StaplesEQUITIES0.95%$1M8.7K
44Wal-Mart De Mexico ADREQUITIES0.92%$1M52.5K
45DOCUDocuSign IncEQUITIES0.90%$1M7.2K
46Invesco QQQ NASDAQEQUITIES0.84%$1M4.7K
47BABAAlibaba Group ADREQUITIES0.84%$1M5.3K
48SHWSherwin Williams CoEQUITIES0.81%$1M1.9K
49ADDYYAdidas AGEQUITIES0.81%$1M8.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$195M204Apr 20, 202613F-HRchanges · EDGAR ↗
Q4 2025$202M176Jan 23, 202613F-HRchanges · EDGAR ↗
Q3 2025$193M174Oct 16, 202513F-HRchanges · EDGAR ↗
Q2 2025$193M194Jul 21, 202513F-HRchanges · EDGAR ↗
Q1 2025$172M186Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$189M196Feb 5, 202513F-HRchanges · EDGAR ↗
Q3 2024$183M195Oct 24, 202413F-HRchanges · EDGAR ↗
Q2 2024$174M183Jul 26, 202413F-HRchanges · EDGAR ↗
Q1 2024Under review193Apr 29, 202413F-HRchanges · EDGAR ↗
Q4 2023$161,346183Feb 6, 202413F-HRchanges · EDGAR ↗
Q3 2023$142,386179Oct 31, 202313F-HRchanges · EDGAR ↗
Q2 2023$147,452185Jul 31, 202313F-HRchanges · EDGAR ↗
Q1 2023$148,801157May 16, 202313F-HRchanges · EDGAR ↗
Q4 2022Under review165Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$131M171Nov 15, 202213F-HRchanges · EDGAR ↗
Q2 2022$136M163Aug 8, 202213F-HRchanges · EDGAR ↗
Q1 2022$186M187May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$196M191Feb 3, 202213F-HRchanges · EDGAR ↗
Q3 2021$180M222Nov 8, 202113F-HRchanges · EDGAR ↗
Q2 2021$197M180Jul 28, 202113F-HRchanges · EDGAR ↗
Q1 2021$183M203Apr 23, 202113F-HRchanges · EDGAR ↗
Q4 2020$176M174Jan 26, 202113F-HRchanges · EDGAR ↗
Q3 2020$154M160Oct 19, 202013F-HRchanges · EDGAR ↗
Q2 2020$137M157Aug 3, 202013F-HRchanges · EDGAR ↗
Q1 2020$111M119Apr 28, 202013F-HRchanges · EDGAR ↗
Q4 2019$132M146Jan 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$121M145Oct 9, 201913F-HRchanges · EDGAR ↗
Q2 2019$117M139Jul 17, 201913F-HRchanges · EDGAR ↗
Q1 2019$113M144Apr 16, 201913F-HRchanges · EDGAR ↗
Q4 2018$97M139Jan 4, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.